Medium-vessel occlusions (MeVOs), that is, occlusions of the M2/3 middle cerebral artery,
A2/3 anterior cerebral artery, and P2/3 posterior cerebral artery segments, account for 25 …

Stroke is one of the leading causes of disability worldwide. Early diagnosis and treatment of
stroke are important for better clinical outcome. Rapid and accurate diagnosis of stroke …

Background and Purpose: Available data on the clinical course of patients with acute
ischemic stroke due to medium vessel occlusion (MeVO) are mostly limited to those with M2 …

As several randomized trials have shown the overwhelming benefit of endovascular
treatment (EVT) compared with medical management alone for acute ischemic stroke (AIS) …

Multiphase CTA offers several important advantages over the traditional single-phase CTA
technique in acute ischemic stroke, including improved detection of large-vessel occlusion …

Approximately one-third of acute ischemic strokes with an identifiable vessel occlusion are
caused by medium vessel occlusion (MeVO), that is, nonlarge vessel occlusions that are …

The cerebral collateral circulation is the main compensatory mechanism that maintains the
ischemic penumbra viable, the tissue at risk for infarction that can be saved if blood flow is …

Stroke remains one of the leading causes of death and disability in Europe. The European
Stroke Action Plan (ESAP) defines four main targets for the years 2018 to 2030. The COVID …

Medium vessel occlusions (MeVOs, ie, M2, M3, A2, A3, P2, and P3 segment occlusions) are
increasingly recognized as a target for endovascular treatment in acute ischemic stroke. It is …

Stroke is a leading cause of disability and mortality, resulting in substantial socio-economic
burden for healthcare systems. With advances in artificial intelligence, visual image …